Oracle, Shares

Oracle Shares Surge on Major U.S. Government Cloud Contracts

17.02.2026 - 07:50:22 | boerse-global.de

Oracle US68389X1054

Oracle Shares Surge on Major U.S. Government Cloud Contracts - Foto: über boerse-global.de

Oracle Corporation's stock posted a gain of nearly 10% this week, marking one of its strongest trading periods of 2026. The rally was fueled by a significant cloud contract from a U.S. federal health agency and a bullish upgrade from a Wall Street analyst, providing a substantial rebound following a weak start to the year.

Key Developments:
* A cloud modernization contract with the Centers for Medicare & Medicaid Services (CMS), covering systems for approximately 150 million insured Americans.
* A separate $88 million fixed-price award from the U.S. Air Force.
* Weekly share price performance: +9.6%.
* Recently announced capital raise plan: $45 to $50 billion.

The upward move commenced on February 9, 2026, when D.A. Davidson analyst Gil Luria raised his rating on Oracle from "Neutral" to "Buy." Luria cited growing confidence in the company's artificial intelligence partnerships and its strategic positioning in the cloud infrastructure market.

This optimism was swiftly validated by substantial government business. On February 11, the CMS announced it had selected Oracle Cloud Infrastructure (OCI) to modernize its technology systems. The agency plans to migrate specific on-premises applications to the cloud, requiring infrastructure that meets the highest security and compliance standards. Oracle's FedRAMP High-certified platform fulfills the stringent federal requirements for handling sensitive healthcare data, which includes processing eligibility and claims information for over 150 million individuals.

"CMS programs are vital to the well-being of countless Americans?a responsibility that demands uncompromising security, reliability, and cost-effectiveness," stated Kim Lynch, Oracle's Executive Vice President for Government and Defense.

A Second Major Defense Award

Momentum continued on February 12 with another federal contract. The U.S. Air Force awarded Oracle an $88 million fixed-price agreement, extending through December 2028, to support its Cloud One program. Under this contract, Oracle will supply cloud infrastructure across multiple classification levels. The deal also includes access to the Oracle AI Database 26ai, which will be utilized for AI workflow development.

Strategic Execution Amidst Broader Plans

These wins underscore Oracle's ongoing campaign to establish OCI as a credible competitor for public cloud workloads within the government sector. The company's 2022 acquisition of Cerner appears to be a cornerstone of this focused healthcare cloud strategy.

Should investors sell immediately? Or is it worth buying Oracle?

The contract announcements arrive shortly after Oracle disclosed an ambitious financing strategy in early February 2026. The technology firm plans to raise between $45 billion and $50 billion through a combination of debt and equity. Proceeds are earmarked for the rapid expansion of data center capacity to support key AI infrastructure clients, including OpenAI, Meta, and xAI.

However, the company continues to face a pending securities fraud class action lawsuit. Several law firms have set a lead plaintiff deadline of April 6, 2026. The litigation alleges Oracle misled investors concerning its AI infrastructure expenditures and revenue projections.

Rebounding from Early-Year Pressure

Oracle's stock has experienced notable volatility in 2026. Prior to the recent surge, shares were down approximately 20% for the year. After reaching an all-time high above $326 in September 2025, the equity came under pressure due to sector-wide software weakness and investor concerns over debt levels and risks associated with its OpenAI partnership.

The new federal contracts provide Oracle with a stream of recurring revenue, which may help alleviate some concerns about execution risks related to its massive AI infrastructure build-out. Market participants will now look ahead to the company's next quarterly earnings report, scheduled for March 9, 2026.

Ad

Oracle Stock: New Analysis - 17 February

Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Oracle analysis...

So schätzen die Börsenprofis Oracle Aktien ein!

<b>So schätzen die Börsenprofis Oracle Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
US68389X1054 | ORACLE | boerse | 68587271 |